That of President Joe Biden The artificial intelligence executive order is a warning to those developing AI systems in healthcare: the government’s laissez-faire approach is coming to an end.
The order – the full text was released last night – envisages, within months, a new regulatory structure that will aim to ensure that AI tools already in use across a large part of the healthcare sector maintain “appropriate levels of quality”.
These areas include AI to help doctors assess patients and diagnose diseases, but also tools that drive research and development of drugs and medical devices, measure quality of care, streamline benefit administration insurance, manage the patient experience and prioritize public health needs.
Because AI systems are constantly learning as they process new data, Biden is directing the Department of Health and Human Services to establish a regulatory structure that can evaluate tools before they come to market and to supervise their performance after they are placed on the market.
This structure would take into account complaints from whistleblowers regarding safety, privacy and security and catalog errors made by AI systems.
Biden wants HHS to ensure this information is well disseminated to providers and patients.
Stimulate innovation: In addition to mitigating the risks of unregulated AI, the order seeks to determine whether AI tools can make care better, cheaper, and more equitable.
The order directs HHS to expedite the provision of grants aimed at:
— develop AI-based tools that create personalized immune response profiles for patients. Researchers envision future therapies tailored to help each patient’s unique immune system fight disease.
— improve the quality of healthcare data on which AI systems rely.
— promote workplace efficiency and job satisfaction by reducing administrative burdens.
– strengthening veteran care and supporting small businesses through two three-month national “AI Tech Sprint” competitions.
And after? Biden gave HHS and other agencies six months to a year to fulfill the order.
This is where we explore the ideas and innovators shaping healthcare.
Ozempic and other weight loss The drugs are causing people to cut back on donuts in several ways: Truist Securities changed its price target for Krispy Kreme shares from $20 to $13 and recommended investors hold the shares rather than buy them more, reports Bloomberg.
In its decision, the financial services company cited uncertainty over drug impact on packaged food stocks.
Send tips securely via SecureDrop, Signal, Telegram or WhatsApp.
Next week, Future Pulse will cover the Milken Institute Future of Health Summit, one of the most important global health events of the year. We’ll report on the politics, policies and trends impacting the future of healthcare in Milken November 6-8.
Today on our Checking the pulse podcast, host Chelsea Cirruzzo speaks with POLITICO reporter Ben Leonard about President Biden’s executive order directing HHS to develop guidelines and oversight for the use of AI in health care.
Doctors are divided on use artificial intelligence in their practices – about the risks, benefits and where it should be used.
How so? Just over half of doctors are excited about the technology, with the rest worried, according to a new survey from Medscapewhich included more than 1,000 doctors of all specialties.
There are areas where doctors have more doubts about the capabilities of the systems. Well over half – 65% – were concerned about the prospect of AI driving diagnostic and treatment decisions.
Many doctors already use AI systems to search for conditions, fill out documents or summarize information, they said. And most consider administrative tasks like scheduling to be the ones most likely to be used later.
One thing most doctors agree on: They need to be informed about AI, with all but one percent saying it is important or very important to stay up to date with the technology.
Anyway: But not everything is positive. Most respondents were concerned about their patients obtaining and following medical advice from AI sources before consulting them.
A slim majority also fears that technology will increase the risk of malpractice litigation.
First Lady of Nigeria, Oluremi Tinubu, Nollywood actors and wives of Nigerian governors are using their star status to reassure citizens that the HPV vaccine, the government began rolling out last weekis safe and should be given to girls ages 9 to 14 to prevent them from developing cervical cancer.
How come? Africa’s most populous country is in the midst of a vaccination campaign aimed at reaching most of the 7.7 million eligible girls.
But Nigerian researchers, with support from UNICEF, found the public skeptical after conducting two rounds of surveys to understand people’s feelings about the virus and the vaccine.
Celebrities are dispelling rumors that the vaccine causes infertility or congenital diseases in babies whose mothers have been vaccinated, said Dr. Dorothy Ochola-Odongo, health officer at UNICEF Nigeria.
Why is this important: Some 8,000 women died from cervical cancer in Nigeria in 2020, the latest year for which data is available.
Access to HPV vaccines in Nigeria and other African countries has been hampered by easing shortages, particularly since a recent study showed that the protection offered by one dose of vaccine was comparable to that delivered by two doses.
Nigeria’s Federal Ministry of Health provides free vaccines, which it purchased with support from Gavi, the Vaccine Alliance; UNICEF; the World Health Organization; and others.